title: Optimizing Active Surveillance.
abstract: Active surveillance is evolving as a management strategy for favorable-risk prostate cancer. Further study is needed to determine the safety of surveillance for specific subgroups of patients, and to clarify the role of genomic markers and image-guided biopsy.
authors.affiliation: The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: hcarter@jhmi.edu.
authors.forename: H Ballentine
authors.initials: HB
authors.lastname: Carter
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics; D006801:Humans; D061705:Image-Guided Biopsy; D008297:Male; D060787:Neoplasm Grading; D011471:Prostatic Neoplasms / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D018570:Risk Assessment; D057832:Watchful Waiting / Q000379:methods*
chemical_list: D014408:Biomarkers, Tumor